Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Medina

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2019
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancerVincenza Conteduca, Elena Castro, Daniel Wetterskog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2025
Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group TrialXavier Garcia-Del-Muro, Begoña P Valderrama, Ana Medina-Colmenero, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2026
Randomized non-comparative phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma unable for cisplatin-based chemotherapy. NIVOTAX TTCC studyLara Iglesias Docampo, Neus Basté, Marc Oliva, et al.
European Urology|February 19, 2019
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate CancerVincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, et al.
European Urology Oncology|October 14, 2023
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM StudyNuria Romero-Laorden, David Lorente, Guillermo de Velasco, et al.
Clinical Genitourinary Cancer|August 19, 2025
Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC StudyCristina Suárez, Òscar Reig Torras, Rafael Morales Barrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2019
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate CancerElena Castro, Nuria Romero-Laorden, Angela Del Pozo, et al.
Acta Crystallographica. Section D, Structural Biology|June 1, 2023
The CCP4 suite: integrative software for macromolecular crystallographyJon Agirre, Mihaela Atanasova, Haroldas Bagdonas, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2019
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancerVincenza Conteduca, Elena Castro, Daniel Wetterskog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2025
Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group TrialXavier Garcia-Del-Muro, Begoña P Valderrama, Ana Medina-Colmenero, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2026
Randomized non-comparative phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma unable for cisplatin-based chemotherapy. NIVOTAX TTCC studyLara Iglesias Docampo, Neus Basté, Marc Oliva, et al.
European Urology|February 19, 2019
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate CancerVincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, et al.
European Urology Oncology|October 14, 2023
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM StudyNuria Romero-Laorden, David Lorente, Guillermo de Velasco, et al.
Clinical Genitourinary Cancer|August 19, 2025
Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC StudyCristina Suárez, Òscar Reig Torras, Rafael Morales Barrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2019
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate CancerElena Castro, Nuria Romero-Laorden, Angela Del Pozo, et al.
Acta Crystallographica. Section D, Structural Biology|June 1, 2023
The CCP4 suite: integrative software for macromolecular crystallographyJon Agirre, Mihaela Atanasova, Haroldas Bagdonas, et al.
Pageof 4